Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 20.45
-0.57 (-2.71%)
Aug 28, 2026, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 2.66 billion as of August 28, 2026. Its market cap has increased by 18.64% in one year.
Market Cap
2.66B
Enterprise Value
2.38B
Revenue
69.53M
Ranking
n/a
PE Ratio
134.82
Stock Price
20.45
ChartMarket Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 2.66B, an increase of 12,634.00%. That is a compound annual growth rate of 25.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 2.66B | 13.07% |
| Dec 31, 2025 | 2.36B | 48.44% |
| Dec 31, 2024 | 1.59B | -50.04% |
| Dec 29, 2023 | 3.18B | 217.33% |
| Dec 30, 2022 | 1.00B | 110.88% |
| Dec 31, 2021 | 474.89M | 222.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.26B |
| Mesoblast | 3.07B |
| PYC Therapeutics | 2.13B |
| Clarity Pharmaceuticals | 932.70M |
| Clinuvel Pharmaceuticals | 530.50M |
| Racura Oncology | 431.35M |
| Tetratherix | 351.10M |
| Starpharma Holdings | 345.86M |